Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation
Source: View publication →
Primary-contact, physiotherapist-led care for uncomplicated musculoskeletal conditions in the emergency department significantly reduces length of stay and improves patient flow without compromising clinical outcomes or safety, while being highly cost-effective.
Key Findings
Study Design
Study Limitations
Clinical Significance
The RESHAP-ED trial provides compelling evidence that deploying physiotherapists as primary-contact practitioners in the ED for simple musculoskeletal injuries is a safe, efficient, and cost-saving strategy. This model safely expedites patient care, enhances patient satisfaction, and can alleviate severe ED congestion by allowing physicians and nurses to focus on high-acuity medical emergencies.
Historical Context
Emergency department overcrowding has become a critical public health crisis globally. Musculoskeletal conditions, which account for a large proportion of ED visits, often experience long wait times because triage prioritizes life-threatening issues. Although primary-contact physiotherapy in EDs has been piloted in various settings over the past two decades, adoption has been inconsistent due to a lack of rigorous, large-scale randomized trials. The RESHAP-ED trial is a landmark study that provides high-quality definitive efficacy, safety, and economic evidence to support widespread implementation of this triage and care model.
Guided Discussion
High-yield insights from every perspective
What are the key elements of a primary survey and red flag screening that a physiotherapist must perform in the ED to differentiate an uncomplicated musculoskeletal injury from a condition requiring urgent medical intervention, such as compartment syndrome or septic arthritis?
Key Response
This tests the student's understanding of foundational MSK clinical reasoning. Primary contact practitioners must reliably rule out red flag conditions. Recognizing the signs of compartment syndrome (pain out of proportion, pain with passive stretch) or septic arthritis (fever, inability to bear weight, joint effusion) is a critical basic skill before managing an uncomplicated sprain.
When triaging a patient with an acute joint injury to a physiotherapist versus an ED physician, how do validated clinical decision rules like the Ottawa Ankle Rules integrate into the initial triage protocol to ensure safe patient streaming and appropriate use of imaging?
Key Response
Residents need to understand systems-based practice and triage criteria. Validated tools help safely stream patients. If a patient requires imaging based on strict criteria, the resident must consider if the physiotherapist has ordering privileges or if physician co-management is required, which directly impacts ED workflow and length of stay.
Given the economic evaluation showing high cost-effectiveness, how might this specific model of physiotherapist-led care impact downstream subspecialty orthopedic referrals and advanced imaging utilization (e.g., early MRI) compared to standard emergency physician care?
Key Response
Fellows must consider broader healthcare utilization and evidence-based medicine. Autonomous physiotherapists often adhere strictly to conservative MSK clinical guidelines, potentially reducing unnecessary advanced imaging and inappropriate early surgical referrals, which heavily drives the cost-effectiveness and aligns with value-based care.
As an ED medical director looking to implement the RESHAP-ED model, what specific medico-legal frameworks, credentialing processes, and interdisciplinary pushback must be navigated to allow physiotherapists to act as primary, autonomous providers for MSK complaints?
Key Response
Attendings and directors deal with implementation science and departmental operations. Empowering allied health professionals as primary providers requires navigating scope-of-practice laws, radiology ordering rights, and potential resistance from medical staff. Understanding these barriers is essential for translating this trial's success into real-world practice.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
The RESHAP-ED trial includes an economic evaluation alongside the RCT. How should investigators account for the potential bias introduced by the unblinded nature of the intervention when calculating Quality-Adjusted Life Years (QALYs) derived from self-reported outcome measures like the EQ-5D?
Key Response
PhD-level critique focuses on methodology. Blinding is impossible in a physiotherapy vs. physician trial. Unblinded patients receiving dedicated one-on-one therapy time may experience a placebo or Hawthorne-like inflation of self-reported quality of life, potentially skewing the incremental cost-effectiveness ratio (ICER). Researchers must use sensitivity analyses to account for this bias.
A critical reviewer might question the generalizability of the RESHAP-ED findings. How do the funding model (e.g., universal healthcare vs. fee-for-service) and the baseline ED crowding metrics of the trial sites threaten the external validity of the cost-effectiveness conclusions?
Key Response
Editors must meticulously assess external validity. Cost-effectiveness in a publicly funded system with specific ED wait time targets (like the UK or Australia) may not translate to a private, fee-for-service model (like the US), where revenue generation, billing scopes of practice, and malpractice environments drastically alter economic incentives.
Based on the RESHAP-ED findings, should international emergency medicine guidelines formally adopt primary-contact physiotherapy as a standard tier of care for acute MSK conditions, and what specific inclusion and exclusion criteria must be codified to ensure the safety profile matches the trial?
Key Response
Guideline committees evaluate whether evidence is strong enough to change standard practice globally. If adopting this as a high-level recommendation, guidelines must explicitly define what constitutes an uncomplicated MSK condition (e.g., excluding polytrauma, suspected fractures requiring reduction, or pediatric cases) to maintain the rigorous safety profile demonstrated in the trial.
Clinical Landscape
Noteworthy Related Trials
UK BEAM Trial
Tested
Physiotherapist-led exercise classes and/or spinal manipulation
Population
Patients with simple low back pain
Comparator
Usual general practitioner care
Endpoint
Disability assessed by the Roland Morris Disability Questionnaire at 3 and 12 months
McClellan Trial
Tested
Extended scope physiotherapist management
Population
ED patients with acute minor soft tissue injuries
Comparator
Standard ED doctor or emergency nurse practitioner care
Endpoint
Clinical outcome and patient satisfaction
STarT Back Trial
Tested
Stratified care including targeted physiotherapy
Population
Primary care patients with acute or subacute low back pain
Comparator
Standard non-stratified medical care
Endpoint
Disability measured by the Roland Morris Disability Questionnaire at 12 months
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis